Video

Barry Borlaug, Mayo Clinic: Heart Failure With Preserved Ejection Fraction

Author(s):

While there's no yet proven treatment for heart failure with preserved ejection fraction, the team is really aiming to understand the pathophysiology to design better targeted treatments.

At the Heart Failure Society of America's 20th Annual Scientific Meeting in Orlando, Fl., Barry Borlaug, MD, Mayo Clinic, discussed his fascination with the relaxation of the heart and his latest research in heart failure with preserved ejection fraction. While there's no proven treatment, the team is really aiming to understand the pathophysiology to design better treatments. For now, the team is limited to controlling blood pressure and any diuretics and treating any of their other conditions until they can find more targeted treatments.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Experts' Perspectives: Top Stories in Cardiology for 2024
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
© 2025 MJH Life Sciences

All rights reserved.